Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The provided string 'VEGFR1, VEGFR2, VEGFR3, PDGFRα, PDGFRβ, FGFR1, FGFR2, FGFR3, FGFR4, c-KIT' does not represent a single, canonical therapeutic target. Instead, it is a list of distinct but related receptor tyrosine kinases, each of which functions as a separate therapeutic target with unique biological roles, disease associations, drug interactions, and specific biomarkers/safety concerns. Therefore, grouping them without separation is imprecise for structured data applications.
Not applicable as this entry represents a collection of distinct therapeutic targets, each with its own specific mechanism of action for interacting drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VEGFR1, VEGFR2, VEGFR3, PDGFRα, PDGFRβ, FGFR1, FGFR2, FGFR3, FGFR4, c-KIT.